These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1076 related items for PubMed ID: 17004293

  • 1. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with respiratory syncytial virus vaccines.
    Piedra PA.
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
    [Abstract] [Full Text] [Related]

  • 3. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R, Qi X, Gong W, Mei X, Wei L, Ma C, Yin X.
    Vaccine; 2007 Oct 16; 25(42):7422-8. PubMed ID: 17850930
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M, Wilschut J, de Haan A.
    Vaccine; 2012 Jan 11; 30(3):597-606. PubMed ID: 22120195
    [Abstract] [Full Text] [Related]

  • 6. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.
    Biochem Biophys Res Commun; 2009 Apr 17; 381(4):528-32. PubMed ID: 19233131
    [Abstract] [Full Text] [Related]

  • 7. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.
    Vaccine; 2007 Oct 10; 25(41):7132-44. PubMed ID: 17850933
    [Abstract] [Full Text] [Related]

  • 8. Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.
    Johnson TR.
    Expert Rev Vaccines; 2006 Jun 10; 5(3):371-80. PubMed ID: 16827621
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease.
    Delgado MF, Polack FP.
    Expert Rev Vaccines; 2004 Dec 10; 3(6):693-700. PubMed ID: 15606354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Basic epidemiology and immunopathology of RSV in children.
    Handforth J, Friedland JS, Sharland M.
    Paediatr Respir Rev; 2000 Sep 10; 1(3):210-4. PubMed ID: 12531081
    [Abstract] [Full Text] [Related]

  • 17. Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    Green CA, Sande CJ, Scarselli E, Capone S, Vitelli A, Nicosia A, Silva-Reyes L, Thompson AJ, de Lara CM, Taylor KS, Haworth K, Hutchings CL, Cargill T, Angus B, Klenerman P, Pollard AJ.
    J Infect; 2019 May 10; 78(5):382-392. PubMed ID: 30742894
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S, Jang JE, Yu JR, Chang J.
    Vaccine; 2010 May 14; 28(22):3801-8. PubMed ID: 20362203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.